Skip to main content
. 2022 Jul 18;13:879900. doi: 10.3389/fimmu.2022.879900

Table 2.

Changes in labortory tests.

Boold test n Baseline Onset of myocarditis p Trend Proportion
ALC (109/L) 34 1.1 (0.7-1.625) 0.6 (0.5-1.2) 0 decrease 26 (76.5)
NLR 34 3.8 (2.35-7.05) 9.8 (4.8-18.4) 0 increase 29 (85.3)
CRP (mg/L) 19 13.45 (5.35-62.225) 31.2 (8.625-94.2) 0.045 increase 12 (63.2)
LDH (U/L) 25 232.1(184.4-311.15) 613 (296-1050.8) 0 increase 21 (84.0)
IL-6 (pg/mL) 16 7.45 (3.725-12.825) 15.4 (7.075-37.375) 0.004 increase 12 (75.0)
IL-10 (pg/mL) 16 2.45 (1.475-5.0) 3.85 (2-7.45) 0.018 increase 13 (81.3)
CK (U/L) 27 63.2 (49.225-107.0) 477.2 (101.0-3214.2) 0 increase 23 (85.2)
CK-MB (U/L) 21 10.0 (2.3-14.0) 39.0 (17.0-103.45) 0 increase 19 (90.5)
BNP (pg/mL) 19 103.8 (35.85-258.25) 1704 (194.1-4848) 0 increase 19 (100.0)

ALC, absolute lymphocyte count; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein; LDH, lactate dehydrogenase; IL-6, interleukin-6; IL-10, interleukin-10; CK, creatine kinase; CK-MB, MB isoenzyme of creatine kinase; BNP, brain natriuretic peptide.